Table 2.
Perioperative outcomes.
| Minimally invasive RC |
Open RC |
p-Value | |
|---|---|---|---|
| n=1 243 | n=855 | ||
| PLND, n (%) | |||
| Standard PLND | 1 159 (93.2) | 811 (94.9) | 0.130 |
| Extended PLND | 84 (6.8) | 44 (5.2) | |
| Urinary diversion, n (%) | <0.001 | ||
| Ileal conduit | 461 (37.1) | 339 (39.7) | |
| Neobladder | 571 (45.9) | 202 (23.6) | |
| Ureterocutaneostomy | 208 (16.7) | 311 (36.4) | |
| Other | 3 (0.2) | 3 (0.4) | |
| Open conversion, n (%) | 27 (2.2) | / | / |
| Operative time, min | 360.6±120.3 | 288.6±90.3 | <0.001 |
| Hospital stays, day | 28.0±9.9 | 25.0±10.0 | <0.001 |
| Positive surgical margin, n (%) | 61 (4.9) | 43 (5.0) | 0.900 |
| Adjuvant chemotherapy, n (%) | 251 (20.2) | 192 (22.5) | 0.212 |
| Lymph nodes yield | 16.2±7.9 | 13.2±5.0 | <0.001 |
| Estimate blood loss, mL | 402.7±517.8 | 623.1±692.9 | <0.001 |
| 90-day postoperative mortality, n (%) | 34 (2.7%) | 24 (2.8%) | 0.922 |
PLND, pelvic lymph node dissection; RC, radical cystectomy.
/, not required to provide.